Leonard Frank X - Sep 15, 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Development Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard
Stock symbol
NVCR
Transactions as of
Sep 15, 2022
Transactions value $
-$1,046,775
Form type
4
Date filed
9/19/2022, 04:10 PM
Previous filing
Sep 12, 2022
Next filing
Sep 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $39.4K +5.52K +7.13% $7.15* 82.9K Sep 15, 2022 Direct F1
transaction NVCR Ordinary Shares Sale -$590K -6.75K -8.15% $87.31 76.2K Sep 15, 2022 Direct F1
transaction NVCR Ordinary Shares Sale -$497K -5.52K -7.24% $90.00 70.6K Sep 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -5.52K -50% $0.00 5.52K Sep 15, 2022 Ordinary Shares 5.52K $7.15 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard.
F2 Fully vested as of the date hereof.